drug · small molecule
osivelotor
Phase 3updated 3mo agoby $PFE PFIZER INC🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2 3 (across all indications), with 3 investigational indications.
indications
indications
Sickle Cell Disease
all catalysts(0)
nothing on the calendar yet
Trials studying osivelotor
- phase1A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults
- phase3A Phase 2/3 Study in Adult and Adolescent Participants With SCD
- phase3GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD)
- phase1A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 12m ago
Found something off?
comments(0)
5-min edit window · permanent after that